Prostate Cancer

Prostate cancer happens when cells in the prostate mutate and grow uncontrollably, exponentially.  Depending on the type of prostate cancer,  however, this form of cancer can grow  slowly or quite rapidly. Some prostate cancers are called indolent and grow very slowly. The conventional treatment is usually what spurs them to be aggressive. (See blog).

Women also have prostate glands, but much smaller and these have other functions, nothing connected to seminal fluid.  Before they were called skene glands, but now they are officially known as female prostate gland and are key in the orgasm process. (1)

The prostate, which tends to become larger with age for mainstream men and women who don’t live a holistic lifestyle, which includes the type of food we were designed to eat, generates part of the fluid that makes up the semen that transports sperm for the preparation of female fertilization. The prostate gland is located under the male bladder and in front of the rectum, so every time there is sexual activity, it gets a decent massage.

Prostate cancer most often develops in the gland cells that produce the seminal fluid. This kind of cancer is called an adenocarcinoma, which is by far the most common type of prostate cancer. Other more rare types of prostate cancer are small cell carcinomas, sarcomas, transitional cell carcinomas and neuroendocrine tumors.

Prostate cancer is the second most common cancer among American men, with non-melanoma skin cancer being the most common. Prostate cancer is the third leading cause of cancer-related deaths overall, and according to the American Cancer Society (ACS), an American man has about a one in seven chance of getting prostate cancer at some time during his life span, so this malignancy needs to be kept at bay holistically, and men, like women should be aware of cancer signs. (2)

Symptoms of prostate cancer

Usually, prostate cancer at an early stage of development does not present any symptoms, it is what is  clinically called “asymptomatic”. When symptoms are present, most often due to later stage cancer, they include the following: Urination issues, such as frequently needing to go (particularly at night), weak urine stream, slow flow and pain during urination. Blood may appear in semen or in urine. Pain in the pelvis, back or hips resulting from cancer that has spread to bones. Numbness or weakness in the feet or legs. Loss of bowel or bladder control when the cancer presses against the spinal cord, fatigue, losing weight, clots and infections. (3)

Screening and diagnosis of prostate cancer

Prostate cancer can often be found early by prostate screening, which is testing to find cancer in patients before symptoms present. Screening, such as the prostate-specific antigen (PSA) evaluation, can detect the cancer at an early stage when it is more likely to respond to conventional treatment. But there’s a downside to cancer screening.

Many times, especially in prostate and breast hormonal dependent cancers, they will resolve on their own. When they do, they are called indolent cancers. (See blog). But most times, they are treated as lethal cancers. Which causes not only a lot of suffering, but this very aggressive treatment spurs new cancers that would never have developed in the first place. (See blog, including on the limitation of conventional oncology). The Institute also does not recommend biopsies. As these can spread the malignancy, when the tumor is really malignant. There are other ways to ascertain malignancy, also other ways than with the PSA, because this cancer marker is not very reliable.

Causes of prostate cancer

Conventional oncologists claim they don’t know what causes prostate cancer, or for that matter just about all cancers and even chronic diseases. If they did know, then they would be liable, because then, they would have a  legal obligation to address the root causes of the malignancy.  But because most conventional oncologists  are educated or miseducated or brainwashed to believe that we don’t really know what causes cancer, mainstream oncologists will only treat the symptoms, like tumors, or isolated growth receptors or now, what is called “checkpoints”. All of these targets are treated symptomatically, not holistically. Hence, the dismal failure of this type of medicine.

If it were not for integrative and holistic oncology to which more than half of the American population goes for complementary lifestyle and alternative consultation, cancer survival statistics would be much worse. For the most part, they are not good, especially if we extend the five “remission” years to ten years. Liquid cancers like leukemia and lymphoma do better five years wise, but complications often ensues later in life.  Be that as it may, instead of talking about causes, conventional oncologists prefer to speak about risks insofar as cancer incidence is concerned. The following are a few, most of which pertain to Americans who don’t live holistically.  Age – Average age at diagnosis is 66 and the chance of getting the disease increases quickly after age 50. Race – African-American men get prostate cancer more often than Caucasian men, as do Jamaicans of African heritage. Hispanic and Asian men are at less risk than Caucasians. Family history – The chance of getting prostate cancer doubles if a man’s father or brother has had prostate cancer. The risk increases if several relatives have had prostate cancer. Geographic location – Prostate cancer is less common in Africa, Asia and South and Central America but more common in North America, the Caribbean, Europe and Australia. Lifestyle –  Conventional oncologists claim that Dietary risks are unclear, even though most admit that men who consume a high-fat diet including a lot of red meat with low consumption of fruits and vegetables can increase a man’s risk. Obesity, smoking, certain chemical exposures  and sexually transmitted infections are also recognized to contribute to increased risks. Genes – Mutations in the BRCA1 and BRCA2 genes increase a man’s risk for prostate cancer, as does having Lynch syndrome, but genetic causes don’t account for many cases overall.

Having a risk factor, or several, does not mean a person will get prostate cancer. In numerous cases people with one or more risk factors never get cancer, depending on their genetic and memetic make-ups, their microbiota and holistic lifestyle. In the longevity zones that the Insitute’s has studied, prostate cancer, like most chronic diseases are virtually nonexistent.

Treatment of prostate cancer

Once prostate cancer has been diagnosed, oncologists can choose from several treatment options. It’s important to think carefully about each choice and weigh the benefits of each treatment against the possible risks and side effects. Common treatment options follow.

Watchful waiting

This may be recommended if the prostate cancer grows slowly and if the man is older and/or has other serious health problems.

Surgery

This is the most common conventional treatment option if the cancer has not spread to other parts of the body (metastasized). A radical prostatectomy is the main surgical treatment, which removes the prostate gland plus the surrounding tissue. This type of surgery can be done in different ways: Retropubic prostatectomy – under general or spinal anesthesia, a small incision is made in the lower abdomen from the belly button to the pubic bone. A catheter is inserted in the penis to drain the bladder and stays in place for 1-2 weeks while the incision heals. The man is able to urinate on his own after the catheter is removed.  Perineal prostatectomy – under general or spinal anesthesia, an incision is made between the scrotum and anus. This procedure usually involves a quicker recovery time and is less painful than a retropubic surgery. Similar to a retropubic surgery, a catheter is placed in the penis for one to two weeks and removed after the incision is healed. Surgeons perform a perineal prostatectomy less often due to a higher risk of erection problems. Laparoscopic prostatectomy – makes several small incisions through which a tube with a camera is inserted, allowing the surgeon to view the area as he or she uses long surgical tools to remove the prostate. In robotic laparoscopic prostatectomy, the surgeon can use a control panel to move robotic arms that hold the tools or use the tools directly. The benefits of laparoscopic surgery are less blood loss and a shorter hospital stay.

Risks and side effects of any type of prostatectomy include blood clots in the lungs, damage to nearby organs, infections at the site of surgery and reactions to the anesthesia. Men might also experience urinary incontinence or erectile dysfunction as a side effect.

Radiation therapy

This is often used for cancer that is still just in the prostate gland. It may also be used in conjunction with other treatments on cancer that has grown outside of the prostate. The two main types of radiation are external beam radiation and internal radiation (brachytherapy).

External radiation focuses the beam on the prostate gland from outside the body with a machine, whereas internal radiation uses small radioactive “seeds” placed directly into the prostate and give off certain amounts of radiation for weeks or months. There are different types of radiation blasts.

Risks and side effects of radiation therapy include tiredness, rectal irritation such as uncomfortable urination or bowel incontinence, dry skin, hair loss and urinary problems such as incontinence or frequent urination.

Cryotherapy

Oncologists often treat early-stage cancer with cryotherapy.  Cryotherapy uses very cold temperatures to freeze and kill prostate cancer cells, inserting hollow needles that inject a gas that freezes the prostate. Cryotherapy is considered a less invasive surgery, but includes side effects such as blood in urine for a day or two, soreness and erectile dysfunction.

Hormone therapy

With conventional oncology, hormonal therapy is often used to reduce the level of male hormones (androgens) if the prostate cancer has spread too far to be cured by surgery or radiation. Types of hormonal therapy include surgical castration, which reduces hormone production, and several types of medications that act on hormone levels.

Some side effects of hormone therapy include erectile dysfunction, hot flashes, weight gain, fatigue, depression or anemia (low red blood cell count).

Chemotherapy

Chemo involves various anti-cancer drugs that are injected into a vein or taken by mouth. The drugs attack cells that are dividing quickly, which is why they work against cancer cells. This treatment is often used if hormone therapy doesn’t work and if the cancer has spread to distant organs. Because other cells in the body divide quickly, such as cells in the bone marrow, lining of the mouth and intestines and hair follicles, these cells can also be affected by chemo. Side effects can include mouth sores, diarrhea, hair loss, nausea and fatigue. These treatments are usually done one at a time, but in some cases can be combined.

Clinical Trials

Clinical trials are research studies that help physicians find new promising treatments and procedures for patients. They offer access to a newer, state-of-the art treatment option. But they may not be the best choice for everyone. Patients interested in a clinical trial should discuss possible options with their doctor..

Prostate cancer occurs when cells grow out of control in the prostate and become cancerous, possibly forming tumors. Cancer of the prostate, the male’s gland that produces some of the seminal fluid that carries sperm in ejaculation, is the second most common cancer among American men, according to the National Cancer Institute. Prostate cancer grows slowly and is associated with age, as most men with the cancer are over age 65. Early stage prostate cancer can show no symptoms, and the main symptoms of advanced stage cancers are difficulties urinating, blood in urine and frequent urges to urinate. Treatment options include surveillance (“watchful waiting”), radiation, chemotherapy and hormone therapy, integrative oncology or what the ARC Institute considers to be the golden standard, holistic oncology, as we have compelling evidence that cancer genes (oncogenes) can be down-regulated while the good cancer genes called tumor suppressor genes can be upregulated to the point where the cancer cells go into apoptosis or get redifferentiated back to  normal cells.

All of this can be done holsitically without cancer necrosis, which means without killing the cancer cells via the fire of ionic radiation, the poison of cytotoxic chemotherapy, the surgical knife surgical oncologists, freezing, hormonal castration and the like.

But the conventional oncologists’ narrow mindset, their training and the huge massive cash-flow oncologists and allopathic hospitals accumulate by practicing conventional oncology are variables that militate against funding clinical trials to show how overwhelming the relevant evidence is.

Be that as it may, we nonetheless have enough evidence, including published evidence, to prove beyond any reasonable doubt that holistic oncology can resolve most cancers including prostate cancers without the medical violence that is still perpetrated today by an outdated sick-care system. Reason would thus command that in an ideal world devoid or structural corruption, systemic violence and massive incompetence and ignorance, we could keep part of conventional oncology’s tools for prostate cancer, notably for those cases that are not amenable to holistic standards nor lifestyle interventions.

But in a world where holistic values prevail over predatory ideologies, the use of these invasive conventional cancer tools should be rare and progressively disappear, just like the arsenic-pigeon poop cataplasm that was medically used by accredited conventional oncologists to treat a massive breast tumor from the Sun King’s mom (Louis’ the XIVth, the one who built Versailles). In clear and for now, today’s conventional and allopathic oncology should be adjunctive at best and kept for people who don’t believe in the evidence-based “magic” of holistic oncology. See the Institute’s blogs and workshops for evidence and details.

Reference and Precision Notes

(1). In 2002, Skene’s gland was officially renamed to female prostate by the Federative International Committee on Anatomical Terminology. (Flam, Faye (2006-03-15). “The Seattle Times: Health: Gee, women have … a prostate?”. seattletimes.nwsource.com). So these Skene’s or female prostate glands, also known as the paraurethral glands, found in females, are homologous to the prostate gland in males. However, anatomically, the uterus is in the same position as the prostate gland, so there are anatomical differences. The female prostate, like the male prostate, secretes PSA and levels of this antigen rise in the presence of carcinoma of the gland. The gland also expels fluid, like the male prostate, notably during orgasm. (Kratochvíl S (1994). “Orgasmic expulsions in women”. Česk Psychiatr (in Czech). 90 (2): 71–7.) (Source)
(2).  The majority of cases happen to men older than 50, with 6 out of 10 diagnosed cases occurring in men over age 65. Average age of diagnosis is 66, and the disease rarely occurs in men under age 40. Even though it is the second most common form of cancer death in men, most men who get prostate cancer do not die from it, partly because most prostate cancers grow very slowly and men tend to get it late in life.
(3).  Theses symptoms are also present with benign prostatic hyperplasia (BPH) also known as an enlarged prostate.

Screen Shot 2015-04-24 at 5.34.39 PM

Disclaimer: Nothing in this educational blog should be construed as medical advise.
2016 (c). Advanced Cancer Research Institute and agents. All Rights Reserved

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Recent Posts

Categories

Translate:

Tags

Translate »
error: Content is protected !!